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CMR and 2D echocardiographic assessment of cardiac volumes, mass and
function. 
Results Among 14 patients (mean age 80.2±8.7 Y [66-91]), a good cor-
relation was found between echocardiography and CMR for LVEF
(56.7±8.1% vs 54.3±9.2%, r=0.8). Echocardiography mildly underesti-
mated LV end diastolic volume (EDV) (55.6±25.8 vs 67±24.1mL/m2,
r=0.84) and end systolic volume (ESV) (24.9±15.8 vs 31.3±13.9mL/m2
r=0.66). Echocardiography overestimated the LV mass (87.4±23.5 vs
64±22.3g/m2, r=0.5). Left atrial volume (assessed by CMR) was increased
(52.8±24.9mL/m2), 8 patients had atrial fibrillation with larger left atrial
volume (71.5±26.9 vs 38.8±10.9mL/m2 for sinus rhythm, p 0.008). Right
ventricular (RV) EDV and ESV assessed by CMR were normal. Mean
RVEF was 43.7±8.7% and RVEF was <45% in 8 (57%) patients who also
had lower LVEF (p=0.005) and higher pulmonary artery systolic pressure
(p=0.01). Late gadolinium enhancement (LGE) was found in 8 cases, 4
with mid-wall LGE, 2 with subendocardial or transmural LGE and 2 with
sub epicardial LGE. 
Conclusion CMR was feasible, safe and was a useful complement to echo-
cardiography in elderly patients hospitalized for HFpEF. In this population,
LVEF assessed by CMR and echocardiography were comparable. Echocardi-
ography underestimated LV volumes and overestimated LV mass. Risk factors
for adverse outcome such as RV dysfunction and the presence of LGE were
found in more than half of the cases. 
The author hereby declares no conflict of interest
0009
Cardiac involvement in hypereosinophilic syndrome: role of multimo-
dality imaging
Blandine Simonnet* (1), Alexis Jacquier (1), Catherine Sportouch-Dukhan
(2), Erwan Donal (3), Erwan Salaun (3), Sandrine Hubert (3), Gilbert
Habib (3)
(1) APHM-CHU la Timone, Marseille, France – (2) CHU Montpellier,
Arnaud de Villeuneuve, Montpellier, France – (3) CHU Rennes,
Pontchaillou, Rennes, France
*Corresponding author: simblan@hotmail.com (Blandine Simonnet)
Cardiac disease occurs in more than 50% of patients with idiopathic
hypereosinophilic syndrome; it is the major cause of morbidity and mor-
tality in patients with this syndrome. The overall mortality is high if
untreated. We aim to rapport recent experience in these cardiac diseases,
especiall echographic features and the contribution of multimodalities
imaging.
This retrospective, descriptive and multicenter study reports the findings of
patients in cardiac centers of Marseille, Montpellier and Rennes between Sep-
tember 2008 and March 2014. Echographic, MRI cardiac, coronarographic,
PET CT, biology and histologic findings are reported. Seven patients have
been reported. Echocardiography is the reference diagnostic method. Classical
findings are progressive endomyocardial thickening, apical obliteration of one
or both ventricles by echogenic material suggestive of fibrosis or thrombus
formation, posterior mitral leaflet involvement and papillary dysfunction
resulting in severe mitral regurgitation. These features are involved in embolic
events or heart failure. MRI helps refine the diagnosis. The characteristic irre-
versible stage shows a circumferential thickened fibrotic sub endocardium
with wall thrombi. The CT identifies non ischemic thrombus excluding coro-
nary artery disease by coronary imaging. Coronary angiography may reveal
fibrosis by the smoothed appearance of the ventricular walls and apical filling.
PET CT shows general signs of myocarditis, such as myocyte necrosis, in the
first stage of the disease.
Symptomatic treatment can lead to cardiac surgery (mitral valve
replacement, resection of endomyocardial fibrosis). Each imaging tech-
nique plays a role in each of the three stages of the disease and the typical
features of myocarditis, thrombus or fibrosis must be identified. Only
seven cases of this rare disease have been identified in three french cardiac
centers since 2008; this too small sample does not allow us to draw statis-
tical conclusions.
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Purpose Transthoracic echocardiography (TTE) for Ebola virus disease
(EVD) might contribute to evaluate gravity, guide treatment, and finally
improve prognosis and has not previously been described. This report delin-
eates the safety, feasibility and clinical implications of systematic TEE for
patients with EVD, in the setting of a deployed French military Ebola virus
disease Treatment Center in Guinea.
Methods In first 48 hours after admission for EVD, a TTE was performed.
All patients were monitored by continue video survey and radio call. Data
were collected prospectively on all cases to include TTE hemodynamic
parameters, and evaluate EVD cardiac complications. Data were collected by
in-live oral transmission to medical center, and correlated to blood test vari-
ables including I-Troponin and Brain Natriuretic Peptide.
Result Eight consecutive patients, hospitalized in March 29th underwent
TTE evaluation performed by a cardiologist during the first 48 hours of
admission. Mean time in Personal Protective Equipment (PPE) was
82 min. No virus accidental exposition during procedure was deplored.
TTE were feasible for all patients and all parameters could be studied. All
TTE showed signs of hypovolemia with low LV pressure filled despite
2 patients with dyspnea; 1 patient had pericarditis effusion (with inappro-
priate sinus bradycardia and elevated troponin), and 1 had previous aspect
of ischemic cardiomyopathy with conserved left ventricular ejection frac-
tion (LVEF).
Conclusion Early use of TTE in Ebola virus disease is safe, effective
and facilitates patient care. It should be considered a feasible additional
exam, where physician expertise and resources allow. In our study,
contrary to the hypotheses previously made, dyspnea had a non-hemody-
namic origin (figure next page).
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Aim We previously developed a data-driven (DD) respiratory-motion (RM) cor-
rection method for conventional SPECT gamma-cameras (REGAT) and adapted it
to the new CZT camera (Discovery NM 530c). We recently reported that RM cor-
rection with REGAT applied to CZT myocardial perfusion SPECT imaging (MPI)
is clinically feasible and impacts substantially myocardial perfusion defects. In this
evaluation, we study whether REGAT applied to MPI (Discovery NM 530c) is
capable of generating a data-driven (DD) cardiac gating signal allowing the
generation of valid global left ventricular (LV) function parameters (EDV: end
diastolic volume; ESV: end systolic volume; EF: ejection fraction). 
Materials and methods Were included 7 patients addressed for stress/rest
MPI. All patients had prone stress MPI (2 MBq/Kg 99mTc-Tetrofosmin) and
rest MPI 3-hours later (6 MBq/Kg). All acquisitions were made on Discovery
NM 530c. Each acquisition was processed with REGAT to generate a dynamic
SPECT acquisition study. The latter was processed to generate a DD cardiac
gating signal and generate a mean DD cardiac GSPECT study (GSPECT-DD).
In parallel, a mean ECG cardiac GSPECT study was generated using the ECG
trigger signal provided by traditional ECG monitor (GSPECT-M). The 2 gene-
rated cardiac GSPECT studies were reconstructed on Xeleris workstation and
processed with Emory Cardiac Toolbox (ECT). LV EDV, ESV and EF were
compared between cardiac GSPECT-DD and GSPECT-M.
Results Stress LV EVD, ESV, and EF were 91±24mL, 29±13ml, and
68±10% vs 95±23ml, 29±12ml, and 70±11% with GSPECT-DD vs GSPECT-
M respectively (P:NS). Rest LV EDV, ESV, and EF were 97±21ml, 32±10ml,
and 67±6% vs 101±21ml, 31±10ml, and 69±6% with GSPECT-DD vs
GSPECT-M respectively (P:NS).
Conclusion Data-driven cardiac gating of MPI with Discovery NM 530c
processed with REGAT is clinically feasible. It provides LV global systolic
function parameters similar to those provided by the traditional clinically used
ECG monitor gating.
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Background Assessment of left ventricular filling pressures (LVFP) is a
key part of echocardiographic evaluation but actual validated parameters
aren’t relevant in some routine cases. Use of diastolic strain rates (DSr)
may improve the diagnostic of elevated LVFP in specific cardiomyo-
pathies. Our primary objective was to evaluate the diagnostic performance
for elevated LVFP of different DSr indexes in a heterogenous cardiological
population.
Material and Methods We led a prospective mono-centric two-dimen-
sional speckle tracking echocardiography study compared to invasive hemo-
dynamic (left catheterization with measurement of pre-atrial pressure (preA)).
Elevation of LVFP was defined as preA>15mmHg. Global DSr indexes tested
were: isovolumetric relaxation DSr (IvrDSr), early DSr (EarlyDSr) and late
DSr (LateDSr). Additional DSr indexes were calculated by meaning of these
parameters: EarlyLateDSr and IvrEarlyLateDSr. DSr values were multiplied
by 10 factor and ratios of E wave to the obtained result gave different
composite E/10DSr indexes. 
Results Fifty height patients were included. Patients with preA>15mmHg
(n=23) were compared with patients with preA<15mmHg (n=35). Mean left
ventricular ejection fraction (LVEF) was 55,7±13,3%, mean preA was
13,6±6,2mmHg.
52% of patients had coronaropathy, 43% had regional dysfunction and 31%
had significant valvulopathy. Correlations to LVFP were: E/10IvrEarlyLateDSr
(R=0,50), E/10LateDSr (R=0,46), E/10EarlyLateDSr (R=0,42). 
Optimal cut off values were 11,5 for E/10LateDSr (sensitivity (Se) 64%,
specificity (Spe) 91%, positive predictive value (PPV) 82% and negative pre-
dictive value (NPV) 80%), 9,5 for E/10EarlyLateDSr (Se 68%, Spe 83%, PPV
71%, NPV 81%) and 15 for E/10IvrEarlyLateDSr (Se 75%, Spe 85%, PPV
79%, NVP 82%). 
Conclusion E/10DSr composite indexes, especially E/10LateDSr and E/
10IvrEarlyLateDSr are relevant LVFP indexes, which may be applied to a
large spectrum of cardiomyopathies.
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# Sex Age LVd IVS
LV wall
motion RVd EF Pericardial effusic IVCd sPAP
Valvular
abnormalities
1 M 48 43 11 Normal 23 75 No 10 20 No
2 F 32 40 9 Normal 20 65 No 10 22 No
3 M 62 47 10 Lateral
hypokinesia
21 50 No 15 28 No
4 F 35 37 7 Normal 19 65 No 8 20 No
5 F 46 40 10 Normal 20 70 No 12 24 No
6 F 32 38 11 Normal 22 65 Yes (<100 ml) 10 18 No
7 M 27 35 9 Normal 21 70 No 7 20 No
8 M 28 32 8 Normal 18 65 No 9 20 No
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